We are live on
!
Find out more
HBK Investments Portfolio holdings
AUM
$10.3B
Turnover
52.97%
1-Year Est. Return
67.69%
This Fund
S&P 500
This Quarter
Est. Return
+5.46%
1 Year Est. Return
+67.69%
3 Year Est. Return
+191.59%
5 Year Est. Return
+445.48%
10 Year Est. Return
+2,540.16%
AUM
$7.66B
AUM Growth
+$586M
(+8.3%)
Cap. Flow
-$631M
Cap. Flow
% of AUM
-8.23%
Top 10 Holdings %
Top 10 Hldgs %
54.23%
Holding
265
New
82
Increased
51
Reduced
40
Closed
50
Avg Time Held Equity + Options
0.5
years
Top 10 Avg Time Held Equity + Options
0.5
years
Top 20 Avg Time Held Equity + Options
0.4
years
Avg Time Held Equity only
0.4
years
Top 10 Avg Time Held Equity only
0.3
years
Top 20 Avg Time Held Equity only
0.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blueprint Medicines
BPMC
|
+$332M |
| 2 |
The AZEK Co
AZEK
|
+$265M |
| 3 |
Hess
HES
|
+$222M |
| 4 |
ChampionX
CHX
|
+$214M |
| 5 |
Dun & Bradstreet
DNB
|
+$192M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intra-Cellular Therapies Inc.
ITCI
|
+$578M |
| 2 |
Berry Global Group, Inc.
BERY
|
+$401M |
| 3 |
Beacon Roofing Supply, Inc.
BECN
|
+$379M |
| 4 |
Paycor HCM, Inc. Common Stock
PYCR
|
+$201M |
| 5 |
Frontier Communications
FYBR
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 39.22% |
| 2 | Energy | 19.03% |
| 3 | Consumer Staples | 9.38% |
| 4 | Healthcare | 7.73% |
| 5 | Industrials | 6.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
DELISTED
Hess
HES
| $1.25B | 16.27% |
9,000,100
+1,644,200
| +22% | +$222M |
2023 Q4
6 quarters
|
|
2
DELISTED
Kellanova
K
| $691M | 9.01% |
8,685,000
-1,309,462
| -13% | -$107M |
2024 Q3
3 quarters
|
|
|
3
DELISTED
Blueprint Medicines
BPMC
| $410M | 5.35% |
+3,200,924
| New | +$332M |
2025 Q2
0 quarters
|
|
|
4
DELISTED
The AZEK Co
AZEK
| $383M | 4.99% |
7,050,978
+5,286,992
| +300% | +$265M |
2025 Q1
1 quarter
|
|
5
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $363M | 4.73% |
587,200
+244,600
| +71% | +$140M |
2023 Q1
9 quarters
|
|
6
DELISTED
Enstar Group
ESGR
| $250M | 3.26% |
743,533
+7,781
| +1% | +$2.6M |
2025 Q1
1 quarter
|
|
|
7
DELISTED
ChampionX
CHX
| $211M | 2.76% |
+8,498,914
| New | +$214M |
2025 Q2
0 quarters
|
|
8
PUT
SPDR Gold Trust
GLD
$142B
| $203M | 2.65% |
667,200
+339,600
| +104% | +$103M |
2024 Q2
4 quarters
|
|
9
DELISTED
Informatica
INFA
| $202M | 2.64% |
+8,298,906
| New | +$171M |
2025 Q2
0 quarters
|
|
|
10
DELISTED
Dun & Bradstreet
DNB
| $195M | 2.55% |
+21,496,107
| New | +$192M |
2025 Q2
0 quarters
|
|
|
11
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$815B
| $185M | 2.42% |
300,000
+150,000
| +100% | +$85.7M |
2023 Q1
9 quarters
|
|
12
DELISTED
Skechers
SKX
| $148M | 1.93% |
+2,347,866
| New | +$135M |
2025 Q2
0 quarters
|
|
13
PUT
Strategy Inc
MSTR
$64.1B
| $148M | 1.93% |
365,700
+94,900
| +35% | +$34.6M |
2024 Q1
5 quarters
|
|
14
DELISTED
Interpublic Group of Companies
IPG
| $147M | 1.91% |
5,990,648
+3,237,855
| +118% | +$78.7M |
2025 Q1
1 quarter
|
|
15
DELISTED
SpringWorks Therapeutics
SWTX
| $123M | 1.6% |
+2,608,340
| New | +$116M |
2025 Q2
0 quarters
|
|
16
ARK 21Shares Bitcoin ETF
ARKB
$3.14B
| $117M | 1.53% |
3,267,144
+815,640
| +33% | +$26.7M |
2024 Q1
5 quarters
|
|
17
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$4.2B
| $109M | 1.43% |
869,000
+617,000
| +245% | +$74M |
2024 Q3
3 quarters
|
|
18
PUT
TSMC
TSM
$2.19T
| $76.8M | 1% |
338,900
-17,100
| -5% | -$3.17M |
2024 Q1
5 quarters
|
|
19
DELISTED
GMS Inc
GMS
| $76.6M | 1% |
+704,721
| New | +$54.5M |
2025 Q2
0 quarters
|
|
20
Fidelity Wise Origin Bitcoin Fund
FBTC
$15.3B
| $73.3M | 0.96% |
780,164
+339,498
| +77% | +$29.2M |
2024 Q1
5 quarters
|
|
21
PUT
iShares Russell 2000 ETF
IWM
$77.5B
| $65.4M | 0.85% |
303,200
-401,200
| -57% | -$80.7M |
2023 Q1
9 quarters
|
|
22
PUT
DoorDash
DASH
$83.6B
| $65.1M | 0.85% |
+264,100
| New | +$53M |
2025 Q2
0 quarters
|
|
23
PUT
iShares Bitcoin Trust
IBIT
$66.2B
| $63.9M | 0.83% |
1,043,900
+512,500
| +96% | +$28.7M |
2024 Q4
2 quarters
|
|
24
DELISTED
Redfin
RDFN
| $63.6M | 0.83% |
+5,662,087
| New | +$55.6M |
2025 Q2
0 quarters
|
|
25
DELISTED
Everi Holdings
EVRI
| $60.3M | 0.79% |
4,233,491
+599,934
| +17% | +$8.39M |
2024 Q4
2 quarters
|
|
Similar funds
BSL
HBK Investments's Q2 2025 Portfolio in Review
As of Q2 2025, HBK Investments held 265 positions worth $7.66B, up 8.3% from $7.08B the previous quarter. Its ten largest holdings account for 54% of the portfolio.
HBK Investments withdrew a net $631M in Q2 2025, closing 50 positions and reducing 40 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $578M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 39% of assets, up from 32% a quarter earlier, followed by Energy and Consumer Staples.
Against the trend, HBK Investments opened a new position in Blueprint Medicines worth $410M.
- HBK Investments's largest Q2 2025 buy was Blueprint Medicines: 3,200,924 shares worth $410M.
- HBK Investments added most to The AZEK Co in Q2 2025, an estimated $265M increase.
- HBK Investments's biggest Q2 2025 reduction was Kellanova, cutting an estimated $107M.
- HBK Investments fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $578M.
- HBK Investments's ten largest holdings make up 54% of its $7.66B portfolio in Q2 2025.
- HBK Investments opened 82 new positions and closed 50 in Q2 2025.
- HBK Investments's portfolio value rose 8.3% quarter-over-quarter to $7.66B.
Based on HBK Investments's 13F filing for Q2 2025, filed 13 Aug 2025.